Vitamin D supplementation promotes macrophages' anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression

Microbes and Infection

Volumn 16, Issue 9, 2014, Pages 755-761

  Lopez Lopez, Nallely ^a   Gonzalez Curiel, Irma ^a   Castañeda Delgado, Julio ^a   Montoya Rosales, Alejandra ^a   Gandara Jasso, Benjamin ^a,b   Enciso Moreno, Jose Antonio ^a   Rivas Santiago, Bruno ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Medical Research Coordination SSA Zacatecas   (Mexico)

Author keywords

Antimicrobial peptides; Cathelicidin; Defensin; Diabetes; Tuberculosis; Vitamin D

Indexed keywords

COLECALCIFEROL; CYCLIC AMP; CYTOCHROME P450; CYTOCHROME P450 27B1; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; ANTIMICROBIAL CATIONIC PEPTIDE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CFU COUNTING; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENE EXPRESSION; HORMONE RESPONSIVE ELEMENT; HUMAN; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; TUBERCULOSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; CELL CULTURE; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; YOUNG ADULT;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CALCITRIOL; VITAMIN D; YOUNG ADULT;

EID: 84908162849     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.06.010     Document Type: Article

References (32)

1. Dye C., Williams B.G. The population dynamics and control of tuberculosis. Science 2010, 328:856-861.
2. WHO Global tuberculosis control report 2009, World Health Organization, Geneva.
3. Dooley K.E., Chaisson R.E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746.
4. Dooley K.E., Tang T., Golub J.E., Dorman S.E., Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009, 80:634-639.
5. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
6. Rivas-Santiago C.E., Hernandez-Pando R., Rivas-Santiago B. Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. Immunotherapy 2013, 5:1117-1126.
7. Mily A., Rekha R.S., Kamal S.M., Akhtar E., Sarker P., Rahim Z., et al. Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis. BMC Pulm Med 2013, 13:23.
8. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl. 1):S43-S48.
9. Wielders J.P., Wijnberg F.A. Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 2009, 55:1584-1585.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
11. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179:2060-2063.
12. Escobedo J., Schargrodsky H., Champagne B., Silva H., Boissonnet C.P., Vinueza R., et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol 2009, 8:52.
13. Guerrero-Romero F., Aradillas-Garcia C., Simental-Mendia L.E., Torres-Rodriguez M.L., Mendoza Ede L., Rosales-Cervantes J., et al. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity. Pediatrics 2013, 131:e1211-1217.
14. Escobedo J., Buitron L.V., Velasco M.F., Ramirez J.C., Hernandez R., Macchia A., et al. High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study. Diabet Med 2009, 26:864-871.
15. White J.H. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008, 76:3837-3843.
16. Battersby A.J., Kampmann B., Burl S. Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol 2012, 2012:430972.
17. Palomer X., Gonzalez-Clemente J.M., Blanco-Vaca F., Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008, 10:185-197.
18. Kibirige D., Mutebi E., Ssekitoleko R., Worodria W., Mayanja-Kizza H. Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda. BMC Res Notes 2013, 6:293.
19. Chun R.F., Peercy B.E., Adams J.S., Hewison M. Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One 2012, 7:e30773.
20. Castaneda-Delgado J., Hernandez-Pando R., Serrano C.J., Aguilar-Leon D., Leon-Contreras J., Rivas-Santiago C., et al. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol 2010, 161:542-550.
21. Gonzalez-Curiel I., Castaneda-Delgado J., Lopez-Lopez N., Araujo Z., Hernandez-Pando R., Gandara-Jasso B., et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol 2011, 72:656-662.
22. Rivas-Santiago B., Rivas Santiago C.E., Castaneda-Delgado J.E., Leon-Contreras J.C., Hancock R.E., Hernandez-Pando R. Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Int J Antimicrob Agents 2013, 41:143-148.
23. Yamshchikov A.V., Kurbatova E.V., Kumari M., Blumberg H.M., Ziegler T.R., Ray S.M., et al. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 2010, 92:603-611.
24. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
25. Lagishetty V., Liu N.Q., Hewison M. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol 2011, 347:97-105.
26. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm 2011, 86:23-62.
27. Schnatz P.F., Nudy M., O'Sullivan D.M., Jiang X., Cline J.M., Kaplan J.R., et al. Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis. Menopause 2012, 19:967-973.
28. Poon A.H., Mahboub B., Hamid Q. Vitamin D deficiency and severe asthma. Pharmacol Ther 2013, 140:148-155.
29. Larcombe L., Mookherjee N., Slater J., Slivinski C., Singer M., Whaley C., et al. Vitamin D in a northern Canadian first nation population: dietary intake, serum concentrations and functional gene polymorphisms. PLoS One 2012, 7:e49872.
30. Larcombe L., Orr P., Turner-Brannen E., Slivinski C.R., Nickerson P.W., Mookherjee N. Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian dene first nations cohort. PLoS One 2012, 7:e40692.
31. Smolders J., Schuurman K.G., van Strien M.E., Melief J., Hendrickx D., Hol E.M., et al. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. J Neuropathol Exp Neurol 2013, 72:91-105.
32. Campbell G.R., Spector S.A. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 2012, 8:1523-1525.